Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ProMIS Neurosciences Q3 EPS $(0.85) Down From $(0.20) YoY

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.85) per share. This is a 325 percent decrease over losses of $(0.20) per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.85) per share. This is a 325 percent decrease over losses of $(0.20) per share from the same period last year.

Keybanc Maintains Overweight on Avid Bioservices, Raises Price Target to $28

By Benzinga Newsdesk

Today, 2:33 PM

Keybanc analyst Paul Knight maintains Avid Bioservices (NASDAQ:CDMO) with a Overweight and raises the price target from $22 to $28.

CDMO

Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact

By Vandana Singh

Today, 2:33 PM

Cigna Corp (NYSE:CI) reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. Q2 adjusted…

What Does Callaway Golf’s Debt Look Like?

By Benzinga Insights

Today, 2:33 PM

Shares of Callaway Golf (NYSE:ELY) fell by 6.90% in the past three months. Before having a look at the importance of debt, let us look at how much debt Callaway Golf has.

ELY